Veolia provides 250 m3/h of additional wastewater treatment capacity to a global pharmaceutical ingredient manufacturer

The Client Needs

A French site of a global manufacturer of active pharmaceutical ingredients needed a quaternary treatment to complement and enhance the performance of the existing wastewater treatment. In particular, they required support in achieving tighter controls on the hard COD while ensuring micropollutants removal to comply with discharge limits.

 

The Solution

Having Veolia as a partner assured the perfect solution for their request: after an initial assessment, we were able to identify the perfect technology combination to address the customer’s needs, reaching an additional treatment capacity of 250 m³/h with the possibility of future expansion.

 

The Result

Fill the form to find out the case study’s details, including the site’s process flow!